Perivascular fibrosis and cardiac hypertrophy can be reduced by E2-induced GPR30 activation, which results in the suppression of inducible NOS (iNOS) activity (represented in the left section of Figure 3) (34). Here, NOS2 is linked to cardiac hypertrophy.